Preparation method of human lysozyme-antibacterial peptide Catesbeianin-1 fusion protein and application of same on preventing and curing cow mastitis

Abstract

The invention discloses a human lysozyme-antibacterial peptide Catesbeianin-1 fusion protein, also provides a gene engineering preparation method thereof, and further provides the application of a fusion protein biological agent on preventing and curing cow mastitis. A human lysozyme and antibacterial peptide Catesbeianin-1 gene is connected with a high-efficiency eukaryotic expression vector in afusion protein form through a gene recombination mode to further enhance the antimicrobial and antiviral activity of the fusion protein so as to obtain an antimicrobial and antiviral recombined protein with higher activity, and the fusion protein is used to prevent and cure the cow mastitis so as to develop a novel medicine which has no chemical medicine residue and antibiotic residue and low medicine resistance and can be used for preventing and curing the cow mastitis,.

Description

technical field [0001] The invention discloses a human lysozyme-antibacterial peptide Catesbeianin-1 fusion protein, and also provides its genetic engineering preparation method. The invention further provides the application of the fusion protein biological preparation in the prevention and treatment of cow mastitis, which belongs to veterinary biology pharmaceutical field. Background technique [0002] Cow mastitis is one of the most common diseases of dairy cows, the most difficult to prevent and cost, and has caused serious harm to the production of dairy cows. Seriously affect the quality of milk, indirectly affect human health, and bring huge economic losses to the dairy industry. [0003] At present, the commonly used drugs for the treatment of cow mastitis are antibiotics, such as ciprofloxacin, penicillin, etc., but due to the serious drug resistance caused by the long-term use of antibiotics, the proportion of coagulase-negative staphylococcus has increased in rec...

AI Technical Summary

Problems solved by technology

[0005] In recent years, although it has been reported to clone the human lysozyme gene for genetic engineering expression and to explore the research on the expression of human lysozyme in transgenic mice, there have also been reports on the cloning and expression of the antimicrobial peptide gene and fusion with other related genes, but no human lysozyme The fusion expression product with antibacterial peptide is used for the treatment of cow mastitis, and there is no patent disclosure related to this project

Images